Medtronic receives FDA approval for defibrillation lead for heart pacing
Medtronic plc (NYSE: MDT) received U.S. Food and Drug Administration approval for an expanded indication for its OmniaSecure defibrillation lead ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)